ProKidney Corp (PROK)
3.03
-0.16
(-5.02%)
USD |
NASDAQ |
Jun 10, 16:00
2.68
-0.35
(-11.55%)
After-Hours: 20:00
ProKidney Free Cash Flow: -132.89M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -132.89M |
| December 31, 2023 | -124.27M |
| September 30, 2023 | -113.38M |
| June 30, 2023 | -84.82M |
| March 31, 2023 | -89.62M |
| Date | Value |
|---|---|
| December 31, 2022 | -78.94M |
| September 30, 2022 | -76.40M |
| June 30, 2022 | -72.71M |
| March 31, 2022 | -63.14M |
| December 31, 2021 | -55.49M |
Free Cash Flow Range, Past 5 Years
-132.89M
Minimum
Mar 2024
-55.49M
Maximum
Dec 2021
-89.17M
Average
-81.88M
Median
Free Cash Flow Benchmarks
| Bio-Path Holdings Inc | -8.92M |
| NKGen Biotech Inc | -15.54M |
| Windtree Therapeutics Inc | -13.86M |
| Veru Inc | -39.87M |
| Lexicon Pharmaceuticals Inc | -185.41M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.65M |
| Cash from Investing (Quarterly) | 58.40M |
| Cash from Financing (Quarterly) | -0.013M |
| Free Cash Flow Per Share (Quarterly) | -0.5842 |
| Free Cash Flow Yield | -70.38% |